Lifeward Q3 2026 net loss widens 59% to $5.05 million
LFWD•Lifeward's third-quarter 2026 net loss widened 59% year over year to $5.05 million, while revenue fell 12% to $5.43 million and gross margin declined to 27.4% from 43.7%. AlterG revenue rose 18% to $3.6 million.
1. Quarterly results
Lifeward's third-quarter 2026 net loss widened 59% year over year to $5.05 million. Revenue fell 12% to $5.43 million, and gross margin dropped to 27.4% from 43.7% a year earlier.
2. Business updates
AlterG revenue climbed 18% to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices. The transition of ReWalk to channel partners affected near-term sales timing; management expects the model to expand patient access and lower operating expenses.
